About a third of people do not respond to their first antidepressant, and what happens next separates good care from years of settling. Alice Tran, PMHNP-BC manages depression medication for Maryland adults by secure telehealth.
Book a Telehealth Appointment →Antidepressant care has a quiet failure mode: a medication gets started, helps somewhat, and then nobody ever revisits it. Residual symptoms get normalized, side effects get tolerated, and "better than before" gets mistaken for "well." Real medication management means measuring progress against remission, not against your worst month, and having a concrete next step when a trial falls short.
The toolkit is deeper than most patients have been shown: SSRIs and SNRIs differ in energy and side-effect profiles; bupropion suits low-energy, low-motivation depression and spares sexual side effects; mirtazapine earns its place when sleep and appetite have collapsed. After partial responses, augmentation and combination strategies follow established evidence. Every switch is cross-tapered thoughtfully, because abrupt changes are where relapses and discontinuation misery come from.
When trials keep failing, the evaluation digs for the reasons: unrecognized bipolarity, thyroid and vitamin issues, sleep apnea, alcohol, or a wrong diagnosis entirely. Genetic testing is available when medication metabolism seems to be part of the story, including considerations specific to patients of Asian ancestry. And if your depression proves genuinely treatment-resistant, Alice says so plainly and helps you reach options like TMS or esketamine programs in Maryland rather than recycling the same trials.
Switch, combine, or augment, chosen by evidence and your history, with a clear timeline for judging each step.
Structured follow-up that tracks symptoms against actual wellness, because residual depression is the strongest predictor of relapse.
Pharmacogenomic insight for repeated side-effect problems or failed trials, including HLA screening relevant to Asian patients.
Honest recognition of treatment resistance and warm referrals to TMS and esketamine programs, without losing your medication home.
Early shifts can appear in two to three weeks; a fair trial at an adequate dose takes six to eight. Follow-ups are scheduled to catch both, so adjustments happen on evidence instead of frustration.
Yes, but not by repeating the past. A history like yours calls for rechecking the diagnosis, screening for bipolarity and medical causes, considering genetic testing, and using augmentation evidence, a genuinely different process than trial five of the same idea.
Often, yes. After a first episode, six to twelve months of wellness is a reasonable point to discuss a slow, monitored taper. That decision is made together, with a plan for what to watch.
Gladly. Therapy plus medication outperforms either alone for most moderate to severe depression, and coordination with your Maryland therapist is standard practice with your permission.
Antidepressant management by telehealth across Maryland.
Book Now →Or call/text: (703) 791-9099